Sign in

CIK 0001671858 · Non-accelerated filer<br>Smaller reporting company

ARS Pharmaceuticals, Inc.

Sign in to watch
Ticker
SPRY
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
811489190
Phone
858-771-9307
Business address
11682 EL CAMINO REAL, SUITE 300, SAN DIEGO, CA, 92130
Former names
Silverback Therapeutics, Inc.
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Planned sale Chief Commercial Officer sold 15,000 shares at $16.00 ($240,000)
  4. 4 Open-market sale Chief Legal Officer sold 102,969 shares at $14.10 ($1,451,513)
  5. 4 Open-market sale Director sold 120,000 shares at $14.25 ($1,710,024)
  6. 4 Open-market sale Chief Financial Officer sold 50,000 shares at $14.10 ($705,165)
  7. 4 Planned sale Director sold 50,002 shares at $12.30 ($615,075)
  8. 4 Planned sale Chief Commercial Officer sold 10,000 shares at $14.00 ($140,000)
  9. 4 Planned sale Director sold 50,000 shares at an average $11.21 ($560,446)
  10. 4 Planned sale Director sold 50,000 shares at $12.31 ($615,565)
  11. 4 Planned sale Director sold 50,000 shares at $11.10 ($555,065)
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Planned sale CHIEF MEDICAL OFFICER sold 100,000 shares at an average $11.67 ($1,167,100)
  20. 4 Planned sale PRESIDENT AND CEO sold 100,000 shares at an average $11.67 ($1,167,100)

Page 3 of 14 · 270 filings